Skip to main content

Welltower guidance

  • WELL · NYSE
  • Real estate
  • Health Care REITs
  • S&P 500
$242.94−0.70%Close 17 Nov 2026 · Market value $177.6B

In its results release of 26 Oct 2026 (Q3 FY2026), Welltower gave 1 forecast in figures, among them FFO of $6.47 to $6.53 for FY2026.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 26 Oct 2026

MeasurePeriodGuidanceAs stated
FFO · RaisedFY2026$6.47 to $6.53We also increased the guidance range of full year normalized FFO attributable to common stockholders to a range of $6.47 to $6.53 per diluted share from the previous range of $6.36 to $6.44

Source: the company's earnings release.

Guidance against results last two years

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
FFOFY2026$6.47 to $6.53Given once—To come

WELL in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.